Personalised Real-time Interoperable Sepsis Monitoring (PRISM)

CompletedOBSERVATIONAL
Enrollment

55

Participants

Timeline

Start Date

November 29, 2023

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2024

Conditions
SepsisAbdominal SepsisInfectionsClinical DeteriorationHemodynamic Instability
Interventions
DEVICE

VIOSync-SPI

The intervention in this study involves an AI-driven clinical decision-support system, VIOSync Sepsis Prediction Index (SPI), designed for the early prediction of sepsis in patients undergoing abdominal surgery. VIOSync integrates data from PPG-based wearable wireless devices that monitor vital signs, electronic health records, and laboratory tests. The AI model analyzes this multimodal data to proactively identify signs of sepsis providing an early warning score, the SPI, to clinicians. The distinguishing feature of this intervention is its use of real-time data and advanced AI analytics to enhance early sepsis detection, aiming to improve patient outcomes in postoperative care.

Trial Locations (1)

41110

General University Hospital of Larissa, Larissa

Sponsors
All Listed Sponsors
collaborator

Larissa University Hospital

OTHER

collaborator

Technical University of Crete

UNKNOWN

lead

Aisthesis Medical P.C.

INDUSTRY

NCT06238180 - Personalised Real-time Interoperable Sepsis Monitoring (PRISM) | Biotech Hunter | Biotech Hunter